Abilify Gambling Lawsuits See New Complaint Alleging Financial Losses Due To Compulsive Gambling Behavior

Print

Abilify Lawsuits Allege The Antipsychotic Medication Causes Excessive Overeating, Gambling, Shopping And Other Impulse Behaviors

Abilify lawsuit compulsive-gambling-lawsuit-side-effects-lawsuits-bottleAbilify Gambling Lawsuit News: A New York man alleges that he became a compulsive gambler and lost more than $10,000 as a result of using Abilify, according to an Abilify gambling side-effect lawsuit filed on his behalf. More than 60 federal Abilify lawsuits are pending in the Northern District of Florida that similarly allege plaintiffs who are prescribed the antipsychotic medication suffer impulse control disorders that can lead to gambling addiction, sex addiction, excessive shopping, overeating, and spending. The Abilify lawsuit complaints assert that the plaintiffs’ impulsive behaviors have resulted in excessive economic losses and emotional distress.
(Abilify Lawsuit Case No. In Re: Abilify (Aripiprazole) Products Liability Litigation – MDL 2734)

The New York man states in his Abilify lawsuit that his compulsive gambling stemmed from taking Abilify from 2014 to 2016. As a result, the plaintiff claims his loss of over $10,000 caused financial instability, emotional distress, and neuropsychiatric and physical injuries. The also alleges that Abilify violates New York’s consumer protection laws. The Abilify lawsuit was filed directly into the Abilify multidistrict litigation (MDL) in the Northern District of Florida and names Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd., which manufactures and markets Abilify, as defendants.
(Abilify Lawsuit Case No. 3:17-cv-00208, U.S. District Court, Northern District of Florida)

“Many other plaintiffs who were prescribed Abilify also allege suffering serious economic losses because of their compulsive gambling, eating, spending and other behaviors,” says Richard Schulte, co-founder of Wright & Schulte LLC.

Wright & Schulte LLC is offering free Abilify gambling lawsuit evaluations to individuals who allegedly sustained significant financial losses and other damages due to an Abilify gambling addiction or other impulse control problems that may be linked to the medication. Please visit our website at www.yourlegalhelp.com or call 1-800-399-0795 for a free Abilify lawsuit consultation or to learn more about your potential legal recourse.

Abilify gambling lawsuits centralized into Multidistrict Litigation

Due to the growing number Abilify gambling lawsuits and those anticipated in the future, plaintiffs asked the U.S. Panel on Multidistrict Litigation to consolidate all federal Abilify gambling lawsuit complaints. In October, the panel granted their request and centralized the Abilify complaints for coordinated pretrial proceedings in the U.S. District Court, Northern District of Florida. All of the federal Abilify lawsuit claims contend that Otsuka Pharmaceuticals and Bristol-Myers Squibb, which makes and markets Abilify, did not adequately warn doctors and their patients that the medication allegedly causes compulsive behaviors.
(Abilify Lawsuit Case No. In Re: Abilify (Aripiprazole) Products Liability Litigation – MDL 2734)

FDA announces Abilify Label Change Due To pathological gambling, compulsive eating, spending or shopping, risky sexual behavior side effects

In May 2016, the U.S. Food and Drug Administration (FDA) announced that the labels of Abilify and related medicines would be updated to reflect the impulse-control risks identified after the agency’s review of 184 cases. The cases involved aripiprazole use and impulse-control problems since Abilify was approved in November 2002. There were 164 cases reported of pathological gambling and the remaining cases involved compulsive eating, spending or shopping, and sexual behaviors. According to the FDA, most patients had no prior history of impulse control disorders prior to taking aripiprazole.
[fda.gov/Drugs/DrugSafety/ucm498662.htm]

Abilify (aripiprazole) an antipsychotic drug to treat schizophrenia

Abilify (aripiprazole) is an atypical antipsychotic drug prescribed to treat schizophrenia, bipolar disorder, major depressive disorders, irritability, aggression, mood swings and other psychological problems. Aripiprazole is sold under the names Abilify, Abilify Maintena, Aristada, and also as generics. Abilify is in a class of drugs called partial dopamine receptor agonists. Dopamine is a neurotransmitter that helps control the brain’s reward and pleasure center. Abilify works by stabilizing the level of dopamine. Studies have found that Abilify may overstimulate the dopamine D3 receptors in the brain that are linked to impulse control.
[fda.gov/Drugs/DrugSafety/ucm498662.htm]

Wright & Schulte LLC And Filing An Abilify Gambling Lawsuit

Wright & Schulte LLC is an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright Schulte LLC stand up for the rights of people who have been injured or wronged, and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you are looking for a law firm that will guarantee the aggressive and personal representation you deserve, do not hesitate to contact Wright & Schulte LLC today. Free Abilify gambling lawsuit case evaluations are available through yourlegalhelp.com, or call 1-888-399-0795.

Contact:
Wright & Schulte LLC
865 S. Dixie Dr.
Vandalia, Ohio 45377
1-800-399-0795
www.yourlegalhelp.com

This entry was posted in Wright & Schulte Lawsuit News. Bookmark the permalink.